FDA Inspection 1014319 — Arizona Center For Reproductive Endocrinology & Infertility

Arizona Center For Reproductive Endocrinology & Infertility — FEI 3005391124

The FDA completed an inspection of Arizona Center For Reproductive Endocrinology & Infertility on Mar 22, 2017 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 22, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tucson, AZ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.